SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-154331
Filing Date
2013-04-15
Accepted
2013-04-15 11:01:24
Documents
6
Period of Report
2013-05-21
Effectiveness Date
2013-04-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d517889ddef14a.htm DEF 14A 805445
2 GRAPHIC g517889g45h63.jpg GRAPHIC 12725
3 GRAPHIC g517889g76q95.jpg GRAPHIC 7377
4 GRAPHIC g517889pc.jpg GRAPHIC 16917
5 GRAPHIC g517889pc1.jpg GRAPHIC 12964
6 GRAPHIC g517889pc_f.jpg GRAPHIC 1211
  Complete submission text file 0001193125-13-154331.txt   877733
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34828 | Film No.: 13760344
SIC: 2834 Pharmaceutical Preparations